logo
Russia's economy is now so militarized, it may keep expanding its army even after the Ukraine war

Russia's economy is now so militarized, it may keep expanding its army even after the Ukraine war

Yahoo4 days ago
Russia's military industry is likely to expand even after the Ukraine war ends, wrote a think tank.
Military spending is driving Russia's economy, sustaining it despite Western sanctions.
Russia's militarized economy is supporting political and economic stakeholders, deterring cutbacks.
Russia's war machine has become such an integral part of its economic engine that its military industry is likely to keep expanding even after the fighting in Ukraine ends, according to a report from the Center for Strategic and International Studies.
"The end of hostilities will not lead to a radical cut-off of military investment," wrote CSIS analysts in a report published on Thursday.
Now in its fourth year, Russia's war with Ukraine continues even as Russian President Vladimir Putin's administration weathers sweeping Western sanctions. And while cracks are starting to show, the Russian economy may still be able to sustain the war effort for several more years, the report said.
Defense spending is set to hit a post-Soviet record of 6.3% of GDP in 2025 and could climb even higher despite mounting signs of economic slowdown or recession.
"Russia's economy appears sustainable for the next few years," the CSIS analysts wrote. They forecast that the Kremlin could maintain its war of attrition through at least 2027.
'Russia could be preparing for some kind of future confrontation with NATO'
The CSIS report comes amid renewed scrutiny of Russia's economy.
Manufacturing activity contracted last month, and employment has suffered. GDP growth slowed to 1.4% in the first quarter, down sharply from 4.5% in the previous quarter.
Still, Russia has defied expectations thanks to its growing military-industrial complex.
"Having become the most sanctioned country in the world, it has managed to maneuver around many economic constraints, keeping revenues from energy sales high and its budget balanced, investing in the military and defense industry, ramping up domestic production of weapons and equipment, and boosting economic growth," wrote the think tank analysts.
Crucially, the militarized economy has built a broad base of political and economic stakeholders — from elites to ordinary workers — who benefit from continued conflict. That makes any significant drawdown in military activity politically and economically unlikely.
Even if a ceasefire is reached, Russia may still be able to rebuild and expand its armed forces over the next decade.
"Russia's war-induced socioeconomic changes have been so significant that the process of societal militarization is unlikely to stop even if the war in Ukraine were to end," wrote the CSIS analysts.
The Kremlin's strategic posture hasn't softened either. CSIS suggests Russia is preparing for a long-term confrontation with NATO, using the war to modernize its forces and test Western resolve.
Beyond conventional arms, Russia has ramped up hybrid warfare, including cyberattacks, disinformation, sabotage, political meddling, and strikes on critical infrastructure. These tools allow Moscow to operate aggressively across multiple fronts.
"Despite being inferior to NATO in terms of its conventional capabilities, today's Russia represents a bigger challenge to European security than it did at the start of 2022," the CSIS analysts wrote.
The Kremlin is learning from past failures, adapting quickly, and growing more confident in what it sees as a West unwilling to stop it.
"Moscow's ongoing large-scale military reforms signal that Russia could be preparing for some kind of future confrontation with NATO within roughly the next decade—including even a large-scale conventional war," they wrote.
Read the original article on Business Insider
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Linde beats second-quarter earnings expectations
Linde beats second-quarter earnings expectations

Yahoo

time2 minutes ago

  • Yahoo

Linde beats second-quarter earnings expectations

(Reuters) -Linde, the world's largest industrial gases company, on Friday reported second-quarter earnings above market expectations, citing higher pricing and continued productivity initiatives across its segments. The U.S.-German company, which supplies gases such as oxygen, nitrogen and hydrogen to factories and hospitals, reported a 6% rise in its adjusted earnings per share to $4.09 in the April-June period. That was ahead of analysts' mean estimate of $4.03 per share, according to LSEG data.

New Tesla sales in Spain rise 27% in July, other EV sales more than double
New Tesla sales in Spain rise 27% in July, other EV sales more than double

Yahoo

time2 minutes ago

  • Yahoo

New Tesla sales in Spain rise 27% in July, other EV sales more than double

(Reuters) -Tesla's new car sales in Spain rose 27% in July from the same month in 2024 to 702 vehicles, registration data released by industry group ANFAC showed on Friday, while sales of electrified cars as a whole skyrocketed, with a 155% rise. Sales of Tesla cars in Spain were up 1.1% in the first seven months of 2025 from the same period a year earlier, while total sales of electrified vehicles, a category that includes both fully electric vehicles and hybrids, were up 93%. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win
Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Yahoo

time2 minutes ago

  • Yahoo

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

LONDON (Reuters) -Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal. Last year, the High Court ruled that one of Moderna's patents relating to the messenger RNA (mRNA) technology which underpinned its COVID-19 vaccine was valid and that Pfizer and BioNTech's Comirnaty vaccine had infringed it, meaning Moderna is entitled to damages in relation to sales after March 2022. The High Court also ruled that the other Moderna patent under challenge in the case was invalid. Moderna was refused permission to appeal against that decision. But Pfizer and BioNTech were granted permission to appeal in an attempt to try and invalidate Moderna's second patent and appealed earlier this month, arguing Moderna's developments of mRNA technology were obvious developments of previous work, rendering the patent invalid. Judge Richard Arnold, however, rejected Pfizer and BioNTech's appeal. Pfizer and BioNTech said in a joint statement that the decision "does not change our unwavering stance that this patent is invalid" and the companies will seek to appeal. "This decision has no immediate impact on Pfizer and BioNTech or Comirnaty," the companies added. Moderna did not immediately respond to a request for comment. Friday's decision in the latest ruling in the legal dispute between the two sides over their competing vaccines, which helped save millions of lives during the pandemic. The companies have also been involved in proceedings in Germany – where a court ruled in Moderna's favour in March – the United States Patent Office, which held that two Moderna COVID-19 vaccine patents were invalid, and elsewhere. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store